Daniel G. Welch - Mar 15, 2023 Form 4 Insider Report for Seagen Inc. (SGEN)

Role
Director
Signature
By: /s/ Jennifer Prosba For: Daniel G. Welch
Stock symbol
SGEN
Transactions as of
Mar 15, 2023
Transactions value $
-$641,704
Form type
4
Date filed
3/17/2023, 04:43 PM
Previous filing
Mar 16, 2023
Next filing
Apr 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGEN Common Stock Options Exercise $79.1K +2.04K +28.22% $38.82 9.26K Mar 15, 2023 Direct F1
transaction SGEN Common Stock Sale -$408K -2.04K -22.01% $200.05 7.22K Mar 15, 2023 Direct F1, F2, F3
transaction SGEN Common Stock Sale -$64K -320 -4.43% $200.05 6.9K Mar 15, 2023 Direct F2, F3
transaction SGEN Common Stock Sale -$249K -1.25K -5.13% $200.05 23.1K Mar 15, 2023 by Trust F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SGEN Non-Qualified Stock Option (right to buy) Options Exercise $0 -2.04K -67.18% $0.00 995 Mar 15, 2023 Common Stock 2.04K $38.82 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F3 Reflects sales of common stock executed in multiple transactions at prices ranging from $200.00 to $200.20. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F4 Options were fully vested on 5/19/17.